1.6 nmol l \m=-\1). In low calcium De Jalon's solution, it also decreased baseline tension IC50 1.5 nmol l \m=-\1) in a concentration-dependent manner. The effect of PTHrP(1-34) on uterine motility decreased as pregnancy progressed until day 13, after which PTHrP(1-34) had no measurable effect on uterine contractility. In contrast, PTHrP(1-34) had no effect on the contractions of the circular smooth muscle of the uterus at any stage of pregnancy. PTHrP(50-69) had no effect on the contractility of either muscle layer of the myometrium. A temporal pattern of staining for PTHrP in the uterus of pregnant rats was observed, and the changes in the staining patterns in the endometrium and myometrium were different in each layer. These data suggest that PTHrP may have at least two distinct roles in the uterus, a relaxing action on longitudinal muscle that depends on the hormonal state of the rat and a novel effect either intraluminally or within the endometrial layer.
Introduction
Parathyroid hormone-related protein (PTHrP) and its messen¬ ger RNA have been identified in tissues involved with repro¬ duction, including the developing and lactating mammary gland (Thiede and Rodan, 1988; Rakopoulos et al, 1992) , placenta (Hellman et al, 1992) , and pregnant myometrium (Thiede et al, 1990) . Although the physiological role of PTHrP in these tissues has yet to be established, the production of PTHrP by placenta and fetal parathyroid have been implicated in the temporal transfer of calcium from mother to embryo in utero (Abbas et al, 1989) . In the uterus, functions such as the control of myometrial contractility to allow successful preg¬ nancy and parturition have also been suggested (Thiede et al, 1990) .
We have demonstrated that PTHrP(l-34) inhibits spon¬ taneous and electrically evoked contractions of the uterus of the cyclic rat in vitro (Paspaliaris et al, 1992) . This response was shown to depend on the stage of the cycle, and was greatest at the time of oestrogen dominance. Similarly, the responsiveness of the immature rat uterus to was enhanced by oestrogen treatment and the response was reduced by ad¬ ditional progesterone treatment (Paspaliaris et al, 1992) .
Because of the requirement for control of uterine motility during pregnancy, the effect of PTHrP(l-34) on the contrac¬ tility of both the longitudinal and circular smooth muscle layers of the pregnant rat uterus was examined.
PTHrP protein and mRNA have been demonstrated in the myometrium (Paspaliaris et al, 1992; Thiede et al, 1991) , and we have also shown that PTHrP and its mRNA are present in the endometrium of the immature rat uterus (Paspaliaris et al, 1992) . As (1989) . The antiserum used was a polyclonal anti-PTHrP(50-69) antiserum (s8094) raised in sheep to synthetic , and has previously been characterized by Danks el al (1989) . This antiserum has previously been used to detect immunoreactive PTHrP in ovine parathyroid gland (Maclsaac et al, 1991) and immature rat uterus (Paspaliaris et al, 1992 (T) . Values are means ± sem (n = 3-5).
As has been reported for PTHrP(75-86) (Barri et al, 1992) , PTHrP(50-69) had no effect on uterine contractility in either longitudinal or circular muscle preparations (data not shown).
Localization of PTHrP in the uterus of pregnant rats PTHrP was localized immunohistochemically in the uterus of pregnant rats, and the pattern of staining changed during pregnancy. Uteri from rats at day 4 of pregnancy ( Fig. 3 a) showed strong positive staining (3) showed the same pattern, with only slightly less intensity (3) than observed at day 4 (not shown).
On day 8 of pregnancy, PTHrP staining was markedly reduced in all layers of the uterus (Fig. 3c) The staining intensity of the smooth muscle surrounding the blood vessels supplying the myometrium and the mesometrium varied in parallel to that of the smooth muscle of the myometrium at all stages of pregnancy examined (Fig. 3a, c) .
At day 4 of pregnancy PTHrP(l-34) was most active in reducing the magnitude of spontaneous contractions and in decreasing the baseline tension of the longitudinal muscle. These responses gradually declined, and PTHrP(l-34) had no effect on myometrial contractility in the last third of pregnancy.
In the uterus of immature rats, the relaxing action of PTHrP(l-34) on uterine myometrium depends on the endocrine status of the rat; it is enhanced by treatment with oestradiol and reduced by subsequent progesterone treatment (Paspaliaris et al., 1992) . Hence, the peak responsiveness of the myometrium of rats at day 4 of pregnancy may be due to the peak in ovarian oestrogen concentration (Shaik, 1971 ) that occurs at this time, whereas the decline in responsiveness may be associated with the increasing dominance of progesterone as pregnancy progresses (Hashimoto el al, 1968 Casey et al (1992) reported that PTHrP is secreted from endometrial stromal cells grown in monolayer culture.
PTHrP produced by these cells could be involved in control of endometrial proliferation and differentiation, as the induction of differentiation has been associated with changes in PTHrP production in keratinocytes (Henderson et al, 1991; Löwik et al, 1992) . PTHrP mRNA is detected in the epithelium of the anti-mesometrial crypts of the uterus, marking the sites of implantation (Beck et al, 1993) . The expression of PTHrP mRNA in the uterine epithelium is followed by the detection of PTHrP mRNA 48 h later in the developing embryo, and PTHrP mRNA can be detected in early post-implantation trophoblastic giant cells (Senior et al, 1991 (Ferguson et al, 1992 
